Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Suarez, Jorge ^a   Gloss, Bernd ^a   Belke, Darrell D ^a   Hu, Ying ^a   Scott, Brian ^a   Dieterle, Thomas ^a   Kim, Yun Kyung ^a   Valencik, Maria L ^b,c   McDonald, John A ^b,c   Dillmann, Wolfgang H ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c George E Wahlen Veteran Affairs Medical Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac myocytes; Heart failure; Sarco(endo)plasmic reticulum Ca2+ ATPase; Transgenic mice

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); DOXYCYCLINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOVASCULAR PERFORMANCE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CARDIOMEGALY; DOXYCYCLINE; GENE EXPRESSION; HEART; HYPERTENSION; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSGENES;

EID: 7244258659     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00428.2004     Document Type: Article

References (29)

1. Arai M, Alpert NR, MacLennan DH, Barton P, and Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993.
2. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, The Netherlands: Kluwer, 2001.
3. Feldman AM, Weinberg EO, Ray PE, and Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73: 184-192, 1993.
4. 2+ transients. Circulation 96: 400-403, 1997.
5. Gloss B, Trost S, Bluhm W, Swanson E, Clark R, Winkfein R, Janzen K, Giles W, Chassande O, Samarut J, and Dillmann W. Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor alpha or beta. Endocrinology 142: 544-550, 2001.
6. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, and Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61: 70-76, 1987.
7. Gwathmey JK and Morgan JP. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res 57: 836-843, 1985.
8. 2+ ATPase (SERCA2) gene expression and calcium reuptake. J Mol Cell Cardiol 28: 2467-2477, 1996.
9. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37: 279-289, 1998.
10. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442, 1994.
11. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 100: 380-389, 1997.
12. 2+ ATPase modifies the transition from hypertrophy to early heart failure. Circ Res 89: 422-429, 2001.
13. 2+-ATPaSe in failing and nonfailing human hearts. Cardiovasc Res 31: 625-632, 1996.
14. Mahler F, Ross J Jr, O'Rourke RA, and Covell JW. Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol 35: 626-634, 1975.
15. 2+-ATPaSe gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85: 305-309, 1990.
16. Meyer M, Bluhm WF, He H, Post SR, Giordano FJ, Lew WY, and Dillmann WH. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol Heart Circ Physiol 276: H779-H785, 1999.
17. 2+]; transients in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 286: H1322-H1330, 2004.
18. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, and Hajjar RJ. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97: 793-798, 2000.
19. Muller OJ, Lange M, Rattunde H, Lorenzen HP, Muller M, Frey N, Bittner C, Simonides W, Katus HA, and Franz WM. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 59: 380-389, 2003.
20. 2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy. FASEB J 17: 61-63, 2003.
21. Sahn DJ, DeMaria A, Kisslo J, and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
22. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
23. 2+ leak-load relationship. Circ Res 91: 594-600, 2002.
24. 2+ exchanger in end-stage human heart failure. Circ Res 75: 443-453, 1994.
25. Suarez J, Belke DD, Gloss B, Dieterle T, McDonough PM, Kim YK, Brunton LL, and Dillmann WH. In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 286: H68-H75, 2004.
26. Sumbilla C, Cavagna M, Zhong L, Ma H, Lewis D, Farrance I, and Inesi G. Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes. Am J Physiol Heart Circ Physiol 277: H2381-H2391, 1999.
27. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 90: 927-935, 1992.
28. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, and Ross J Jr. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94: 1109-1117, 1996.
29. Valencik ML and McDonald JA. Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart. Transgenic Res 10: 269-275, 2001.